Skip to content

SEGATROM: Sensory and Gastrointestinal Impact of Taste Receptor Variants on Human Metabolism and Nutrition

Sensory and Gastrointestinal Impact of Taste Receptor Variants on Human Metabolism and Nutrition

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02219295
Acronym
SEGATROM
Enrollment
97
Registered
2014-08-18
Start date
2011-12-31
Completion date
2014-09-30
Last updated
2020-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorder of Glucose Regulation

Keywords

SGLT1 (sodium dependent glucose transporter), Glut-transporters, taste receptors genes, sweet taste receptor T1R2T1R3, bitter taste receptors of the hTAS2gene family

Brief summary

We investigate the impact of taste receptors (sweet, bitter and umami) on human metabolism. There ist growing evidence, that components of the taste signalling system, including the taste receptor proteins , have important functions in the regulation of metabolic parameters in non-gustatory tissues.

Detailed description

We apply different sweet, bitter and umami taste compounds in a single dose in the human intervention. We use substances as for instance glucose, sucrose,saccharin and lactisol in the sweet part, and substances from cabbage, beer or red endive in the bitter part. For umami we take glutamate. Blood samples are collected at baseline and 6 times thereafter up to 3hours, to analyse the incretins GLP-1(glucagon-like peptide 1) and GIP(gastrointestinal polypeptide) and other peptide hormones as insulin and PYY(peptide tyrosin trosin) in human beings. Gastrointestinal mucosa is taken by gastroscopy from the lower duodenum from study subjects for analysis for the presence or absence of functional taste receptors in gastrointestinal tissues.

Interventions

DIETARY_SUPPLEMENTsweet block

oral application of the above mentioned substances in 300 ml tap water in 5 min. , collection of blood at 0,15,30, 60 ,120,180 minutes for measurement of incretins GIP(gastrointestinal polypeptide) and GLP-1 (glucagon like peptide 1), Protein hormones PYY(Peptide YY),CCK (cholecystokinin), Leptin and Insulin

DIETARY_SUPPLEMENTbitter block

oral application of the above mentioned substances in 300 ml tap water, collection of blood samples at -15,0,15,30,60,120,180 min for Insulin, GIP,GLP-1, PYY and glucose

DIETARY_SUPPLEMENTumami-block

oral application of umami substances as glutamate with and without IMP, collection of blood samples as above

OTHERgastroscopy

gastroscopy with and without oral application of saccharin, tissue samples from th upper duodenum by endoscopy for the detection of taste receptor cells in the upper bowel

Sponsors

Technical University of Munich
CollaboratorOTHER
German Institute of Human Nutrition
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy persons

Exclusion criteria

* Tumor in history * Pregnancy * Severe illness in history * Bodymass index below 18

Design outcomes

Primary

MeasureTime frameDescription
Area under the curve (AUC): changes of expression levels of the sweet , bitter und umami taste receptors in humans in the upper bowel and responses of incretins to receptor agonists and antagoniststhree yearsmeasurement of incretins (GIP, GLP-1) and peptide hormones in human plasma after consumption of different sugars , sweeteners , bitter tasting ingredients of vegetables und umami. Measurement of expression levels in human intestinal mucosa before and after receptor stimulation

Secondary

MeasureTime frameDescription
changes in the signalling cascade of the sweet receptor SGLT1 (sodium tranporter 1), changes of receptor expression3 yearsoral application of sweet tasting substances and antagonists, endoscopic collection of tissue samples, determination of molecular resonses by qRT-PCR and immunohistochemistry

Other

MeasureTime frameDescription
Changes in the Area under the Curve (AUC) for PYY in different bitter tasting substances3 yearsoral application of sinigrin, lactucopicrin and other extracts of vegetables and umami, getting insight into the different bitter receptors

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026